1. Home
  2. FN vs BBIO Comparison

FN vs BBIO Comparison

Compare FN & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FN
  • BBIO
  • Stock Information
  • Founded
  • FN 1999
  • BBIO 2015
  • Country
  • FN Cayman Islands
  • BBIO United States
  • Employees
  • FN N/A
  • BBIO N/A
  • Industry
  • FN Telecommunications Equipment
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FN Utilities
  • BBIO Health Care
  • Exchange
  • FN Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • FN 8.2B
  • BBIO 7.6B
  • IPO Year
  • FN 2010
  • BBIO 2019
  • Fundamental
  • Price
  • FN $266.16
  • BBIO $41.73
  • Analyst Decision
  • FN Buy
  • BBIO Strong Buy
  • Analyst Count
  • FN 7
  • BBIO 13
  • Target Price
  • FN $246.43
  • BBIO $56.67
  • AVG Volume (30 Days)
  • FN 495.9K
  • BBIO 2.5M
  • Earning Date
  • FN 08-18-2025
  • BBIO 07-31-2025
  • Dividend Yield
  • FN N/A
  • BBIO N/A
  • EPS Growth
  • FN 18.98
  • BBIO N/A
  • EPS
  • FN 8.97
  • BBIO N/A
  • Revenue
  • FN $3,262,896,000.00
  • BBIO $127,415,000.00
  • Revenue This Year
  • FN $21.16
  • BBIO $102.05
  • Revenue Next Year
  • FN $12.83
  • BBIO $54.69
  • P/E Ratio
  • FN $29.34
  • BBIO N/A
  • Revenue Growth
  • FN 17.14
  • BBIO N/A
  • 52 Week Low
  • FN $148.55
  • BBIO $21.62
  • 52 Week High
  • FN $281.79
  • BBIO $41.90
  • Technical
  • Relative Strength Index (RSI)
  • FN 70.60
  • BBIO 69.82
  • Support Level
  • FN $231.51
  • BBIO $39.65
  • Resistance Level
  • FN $268.62
  • BBIO $41.36
  • Average True Range (ATR)
  • FN 8.31
  • BBIO 1.51
  • MACD
  • FN 1.97
  • BBIO 0.35
  • Stochastic Oscillator
  • FN 93.53
  • BBIO 97.37

About FN Fabrinet

Fabrinet provides advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: